La vendita allo scoperto per BrightView Hldgs dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di BrightView Hldgs. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

BrightView Hldgs (NYSE:BV) Azioni, Report sulle vendite allo scoperto

BrightView Hldgs

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

BrightView Holdings

BrightView Holdings Inc

BIOVAXYS TECHNOLOGY CORP by BioVaxys Technology Corp.

BioVaxys Technology Corp

BATM ADVANCED COMM by BATM Advanced Communications GBP

BATM Advanced Communications Ltd

MARIE BRIZARD W & S ORD by MARIE BRIZARD WINE & SPIRITS SA

Beaver Coal Ltd

BV Financial Inc

Bluegreen Vacations Holdings Corp Com Cl A

Bluegreen Vacations Holding Corp Class B

Vistry Group PLC

VISTRY GROUP PLC UNSP/ADR by VISTRY GROUP PLC.

BREVILLE GROUP LTD by Breville Group Ltd.

Breville Group Ltd

BREVILLE GRP UNSP/ADR by Breville Group Ltd.

Bold Ventures Inc

Compañía de Minas Buenaventura SAA

BAVARIAN NORDIC A S by Bavarian Nordic A/S

Bavarian Nordic AS

BevCanna Enterprises Inc

BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S

Bureau Veritas SA

Bioventus Inc

BRAVURA SOLUTIONS LTD by Bravura Solutions Ltd.

Bravura Solutions Ltd

Iconic Minerals Ltd Ordinary Shares - New

BRAVATEK SOLUTIONS by Bravatek Solutions, Inc.

Bravatek Solutions Inc

BIVICTRIX THERAPEUTICS PL by BIVICTRIX THERAPEUTICS PLC

BiVictriX Therapeutics PLC

BUREAU VERITAS SA UNS/ADR by Bureau Veritas SA

5 analysts have expressed a variety of opinions on BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $17.18, a high estimate of $20.00, and a low estimate of $12.90. Observing a 14.0% increase, the current average has risen from the previous average price target of $15.07. 
<img src="https://www.benzinga.com/files/images/story/2024/1731697221_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of BrightView Hldgs by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Stevenson</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$20.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$12.90</td>
<td>$11.30</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$20.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Stephanie Moore</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$17.00</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to BrightView Hldgs. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of BrightView Hldgs compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of BrightView Hldgs's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of BrightView Hldgs's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BV/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on BrightView Hldgs analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>All You Need to Know About BrightView Hldgs</h2>
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
<h3>Unraveling the Financial Story of BrightView Hldgs</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Decline in Revenue: Over the 3 months period, BrightView Hldgs faced challenges, resulting in a decline of approximately -3.55% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 1.26%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): BrightView Hldgs's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 0.74%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.28%, the company showcases effective utilization of assets.
Debt Management: BrightView Hldgs's debt-to-equity ratio is below the industry average at 0.71, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Analyst Scoreboard: 5 Ratings For BrightView Hldgs

Loop Capital analyst Jeffrey Stevenson maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Buy and raises the price target from $18 to $20.

News

Price Target

Loop Capital Maintains Buy on BrightView Hldgs, Raises Price Target to $20

Goldman Sachs analyst George Tong maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Sell and raises the price target from $11.3 to $12.9.

Goldman Sachs Maintains Sell on BrightView Hldgs, Raises Price Target to $12.9

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler analyst Kashy Harrison upgraded the rating for Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) from Neutral to Overweight and raised the price target from $10 to $20. Bloom Energy shares closed at $13.28 on Thursday. <a href="https://www.benzinga.com/quote/BE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham analyst Charles Shi upgraded Kulicke and Soffa Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLIC#NASDAQ">KLIC</a>) from Hold to Buy and announced a $55 price target. Kulicke &amp; Soffa shares closed at $45.61 on Thursday. <a href="https://www.benzinga.com/quote/KLIC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>William Blair analyst Tim Mulrooney upgraded the rating for BrightView Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) from Market Perform to Outperform. BrightView shares closed at $15.81 on Thursday. <a href="https://www.benzinga.com/quote/BV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Vicki Stern upgraded the rating for InterContinental Hotels Group PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHG#NYSE">IHG</a>) from Equal-Weight to Overweight. InterContinental Hotels shares closed at $122.05 on Thursday. <a href="https://www.benzinga.com/quote/IHG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Redburn Atlantic analyst Simon Baker upgraded Autolus Therapeutics plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) from Neutral to Buy and announced a $13 price target. Autolus Therapeutics shares closed at $3.01 on Thursday. <a href="https://www.benzinga.com/quote/AUTL/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/42000528/dow-dips-over-200-points-following-economic-reports-tesla-tumbles-on-potential-removal-of-ev-tax-credit-fear-index-remains-in-greed-zone">Dow Dips Over 200 Points Following Economic Reports, Tesla Tumbles On Potential Removal Of EV Tax Credit: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Upgrades

Pre-Market Outlook

Markets

Trading Ideas

AUTL

KLIC

This InterContinental Hotels Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

William Blair analyst Tim Mulrooney upgrades BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) from Market Perform to Outperform.

William Blair Upgrades BrightView Hldgs to Outperform

Baird analyst Andrew Wittmann maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Outperform and raises the price target from $18 to $20.

Baird Maintains Outperform on BrightView Hldgs, Raises Price Target to $20

Company Provides Fiscal Year 2025 Guidance1
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Revenue</td>
<td colspan="1" rowspan="1">$2.750 - $2.840 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA2</td>
<td colspan="1" rowspan="1">$335 - $355 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Free Cash Flow2</td>
<td colspan="1" rowspan="1">$40 to $60 million</td>
</tr>
</tbody>
</table>
</figure>
"Fourth quarter results reconfirmed the delivery of a breakout year in fiscal 2024 as we continue to transform this business. Our One BrightView culture is gaining traction, and we are positioned for fiscal 2025 to be a second consecutive record year," said BrightView President and Chief Executive Officer Dale Asplund. "Our multi-faceted transformation has positioned us to prioritize our employees and customers and reinvest in our business, ultimately leading to sustainable growth and value creation for all of our stakeholders."
-------
1For assumptions underlying the 2025 guidance, see the Q4 2024 presentation at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestor.brightview.com%2Foverview%2Fdefault.aspx&amp;esheet=54152181&amp;newsitemid=20241113164687&amp;lan=en-US&amp;anchor=investor.brightview.com&amp;index=1&amp;md5=08e4b6a47eeb8b9456e07f0b5f9a8b12">investor.brightview.com</a> &nbsp;

Guidance

BrightView Sees FY25 Revenue $2.75B-$2.84B Vs $2.8B Est.

BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.31 by 3.23 percent. This is a 57.89 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $728.70 million which beat the analyst consensus estimate of $723.19 million by 0.76 percent. This is a 1.95 percent decrease over sales of $743.19 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

BrightView Hldgs Q4 Adj $0.30 Misses $0.31 Estimate, Sales $728.70M Beat $723.19M Estimate

ACXP

ADAP

AEMD

AFCG

AFYA

AGRO

AIRJ

ALUR

ALVO

ARCO

ATEX

AYTU

BCDA

BETR

BFRI

BITF

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BNGO

BOXL

BRFS

BWEN

CAAS

CAPR

CREX

CRNT

CSAN

CSCO

CSLR

CSTE

CYBR

DADA

DGII

DMAC

DOLE

DRRX

DTCK

ECOR

EDBL

ENLT

EZPW

FORA

FPAY

FULC

GILT

GLAD

GOEV

GRYP

HIVE

HROW

HYZN

IBTA

ICAD

ICCC

INLX

INVZ

JAGX

JJSF

KBDC

KMDA

KRMD

KULR

LMFA

LOAR

LQDA

LUCD

LVLU

MCRB

MPTI

MRSN

NTWK

NXGL

OMER

OPRX

OTRK

OWLT

OXBR

PAVM

PCYO

Earnings Scheduled For November 13, 2024

BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that BrightView Hldgs will report an earnings per share (EPS) of $0.30.
Anticipation surrounds BrightView Hldgs's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 7.23% increase in the share price the next day.
Here's a look at BrightView Hldgs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.32</td>
<td>0.07</td>
<td>0.04</td>
<td>0.33</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.32</td>
<td>0.11</td>
<td>0.02</td>
<td>0.19</td>
</tr>
<tr>
<td>Price Change %</td>
<td>7.000000000000001%</td>
<td>11.0%</td>
<td>-1.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1731423684_0.png" alt="eps graph" />
<h3>Tracking BrightView Hldgs's Stock Performance</h3>
Shares of BrightView Hldgs were trading at $18.73 as of November 11. Over the last 52-week period, shares are up 141.53%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Insights Shared by Analysts on BrightView Hldgs</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on BrightView Hldgs.
With 2 analyst ratings, BrightView Hldgs has a consensus rating of Buy. The average one-year price target is $16.5, indicating a potential 11.91% downside.
<h3>Analyzing Analyst Ratings Among Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of CECO Environmental, Aris Water Solutions and Montrose Environmental Gr, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>For CECO Environmental, analysts project an Buy trajectory, with an average 1-year price target of $34.0, indicating a potential 81.53% upside.</li>
<li>The prevailing sentiment among analysts is an Buy trajectory for Aris Water Solutions, with an average 1-year price target of $23.5, implying a potential 25.47% upside.</li>
<li>Montrose Environmental Gr is maintaining an Buy status according to analysts, with an average 1-year price target of $42.17, indicating a potential 125.15% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
In the peer analysis summary, key metrics for CECO Environmental, Aris Water Solutions and Montrose Environmental Gr are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>BrightView Hldgs</td>
<td>Buy</td>
<td>-3.55%</td>
<td>$177.60M</td>
<td>0.74%</td>
</tr>
<tr>
<td>CECO Environmental</td>
<td>Buy</td>
<td>-9.29%</td>
<td>$45.27M</td>
<td>0.88%</td>
</tr>
<tr>
<td>Aris Water Solutions</td>
<td>Buy</td>
<td>12.55%</td>
<td>$45.78M</td>
<td>2.21%</td>
</tr>
<tr>
<td>Montrose Environmental Gr</td>
<td>Buy</td>
<td>6.40%</td>
<td>$73.09M</td>
<td>-2.97%</td>
</tr>
</tbody>
</table>

Key Takeaway:
BrightView Hldgs ranks in the middle for revenue growth among its peers. It has the highest gross profit margin. The company's return on equity is below average compared to its peers.
<h3>About BrightView Hldgs</h3>
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
<h3>BrightView Hldgs: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Negative Revenue Trend: Examining BrightView Hldgs's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -3.55% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: BrightView Hldgs's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.26% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.74%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): BrightView Hldgs's ROA excels beyond industry benchmarks, reaching 0.28%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.71.
<a href="https://www.benzinga.com/quote/BV/earnings">To track all earnings releases for BrightView Hldgs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look Ahead: BrightView Hldgs's Earnings Forecast

Morgan Stanley analyst Toni Kaplan initiates coverage on BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Equal-Weight rating and announces Price Target of $16.

Initiation

Morgan Stanley Initiates Coverage On BrightView Hldgs with Equal-Weight Rating, Announces Price Target of $16

WIIM

BrightView Holdings shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target on the stock from $13 to $17.

In the preceding three months, 6 analysts have released ratings for BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $15.88, a high estimate of $18.00, and a low estimate of $11.30. This current average has increased by 24.06% from the previous average price target of $12.80. 
<img src="https://www.benzinga.com/files/images/story/2024/1724263247_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of BrightView Hldgs among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Stephanie Moore</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$17.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$14.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>George Kelly</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$11.30</td>
<td>$10.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Jeffrey Stevenson</td>
<td>Loop Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$18.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to BrightView Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of BrightView Hldgs compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of BrightView Hldgs's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into BrightView Hldgs's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BV/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on BrightView Hldgs analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know BrightView Hldgs Better</h2>
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
<h3>BrightView Hldgs: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining BrightView Hldgs's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -3.55% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: BrightView Hldgs's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 1.26%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.74%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.28%, the company showcases effective utilization of assets.
Debt Management: BrightView Hldgs's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.71.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 6 Analyst Recommendations For BrightView Hldgs

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page.</a>
<ul>
<li>Jefferies raised the price target for BrightView Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) from $13 to $17. Jefferies analyst Stephanie Moore upgraded the stock from Hold to Buy. BrightView shares fell 2.9% to close at $14.54 on Tuesday. <a href="https://www.benzinga.com/quote/BV/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo cut the price target for Sonoco Products Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SON#NYSE">SON</a>) from $54 to $52. Wells Fargo analyst Gabe Hajde downgraded the stock from Equal-Weight to Underweight. Sonoco shares fell 0.5% to close at $50.57 on Tuesday. <a href="https://www.benzinga.com/quote/SON/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup raised Texas Instruments Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) price target from $200 to $235. Citigroup analyst Christopher Danely upgraded the stock from Neutral to Buy. Texas Instruments shares gained 0.9% to close at $202.54 on Tuesday. <a href="https://www.benzinga.com/quote/TXN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird boosted the price target for Medtronic plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) from $82 to $90. Baird analyst David Rescott maintained a Neutral rating. Medtronic shares gained 0.7% to close at $85.38 on Tuesday. <a href="https://www.benzinga.com/quote/MDT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley raised Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) price target from $98 to $100. Morgan Stanley analyst Andrew Percoco maintained an Equal-Weight rating. Enphase Energy shares fell 2.3% to close at $116.98 on Tuesday. <a href="https://www.benzinga.com/quote/ENPH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities slashed Cogent Communications Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCOI#NASDAQ">CCOI</a>) price target from $75 to $65. B of A Securities analyst David Barden downgraded the stock from Neutral to Underperform. Cogent Communications shares fell 1.4% to close at $74.73 on Tuesday. <a href="https://www.benzinga.com/quote/CCOI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho increased the price target for Corning Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) from $44 to $47. Mizuho analyst John Roberts upgraded the stock from Neutral to Outperform. Corning shares gained 0.3% to close at $40.73 on Tuesday. <a href="https://www.benzinga.com/quote/GLW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>CLSA cut Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) price target from $15.8 to $12. CLSA analyst Leo You downgraded the stock from Outperform to Hold. Vipshop shares dipped 17.6% to close at $11.56 on Tuesday. <a href="https://www.benzinga.com/quote/VIPS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James boosted Agree Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) price target from $70 to $81. Raymond James analyst RJ Milligan maintained a Strong Buy rating. Agree Realty shares fell 0.2% to close at $72.17 on Tuesday. <a href="https://www.benzinga.com/quote/ADC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Maxim Group slashed Dermata Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRMA#NASDAQ">DRMA</a>) price target from $10 to $6. Maxim Group analyst Anthony Vendetti maintained a Buy rating. Dermata Therapeutics shares fell 6.1% to close at $2.02 on Tuesday. <a href="https://www.benzinga.com/quote/DRMA/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying TXN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="514" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182-1024x514.png" alt="" class="wp-image-506185" style="width:542px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182-1024x514.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182-768x386.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21085756/image-182.png 1346w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40478428/s-p-500-nasdaq-fall-after-8-session-winning-streak-ahead-of-powells-comments-and-fed-meeting-outcom">S&amp;P 500, Nasdaq Fall After 8-Session Winning Streak Ahead Of Powell&#8217;s Comments And FOMC Minutes: Fear &amp; Greed Index In &#8216;Neutral&#8217; Zone</a></li>
</ul>

CCOI

DRMA

ENPH

VIPS

Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday

Jefferies analyst Stephanie Moore upgrades BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) from Hold to Buy and raises the price target from $13 to $17.

Jefferies Upgrades BrightView Hldgs to Buy, Raises Price Target to $17

JP Morgan analyst Andrew Steinerman maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Underweight and raises the price target from $11 to $14.

JP Morgan Maintains Underweight on BrightView Hldgs, Raises Price Target to $14

Goldman Sachs analyst George Kelly maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Sell and raises the price target from $10 to $11.3.

Goldman Sachs Maintains Sell on BrightView Hldgs, Raises Price Target to $11.3

Baird analyst Andrew Wittmann maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Outperform and raises the price target from $17 to $18.

Baird Maintains Outperform on BrightView Hldgs, Raises Price Target to $18

BrightView Sees Q3 2024 Free Cash Flow $65M-$80M Vs $55M-$75M Prior

BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) reported quarterly earnings of $0.32 per share which met the analyst consensus estimate. The company reported quarterly sales of $738.80 million which missed the analyst consensus estimate of $741.00 million by 0.30 percent. This is a 3.55 percent decrease over sales of $766.00 million the same period last year.

BrightView Hldgs Q3 2024 Adj. EPS $0.32, Inline, Sales $738.80M Miss $741.00M Estimate

Baird raised the firm's price target on BrightView (BV) to $20 from $18 and keeps an Outperform rating on the shares. The firm said there is no cha...

BrightView price target raised to $20 from $18 at Baird

BrightView (BV) is down -17.8%, or -$3.25 to $15.00. Published first on TheFly – the ultimate source for real-time, market-moving breaking financia...

BrightView falls -17.8%

BrightView Holdings, Inc. (BV) Q3 2024 Earnings Call Transcript

Goldman Sachs raised the firm's price target on BrightView (BV) to $12.90 from $11.30 but keeps a Sell rating on the shares. The company reported m...

BrightView price target raised to $12.90 from $11.30 at Goldman Sachs

Brightview Holdings ( ($BV) ) has released its Q4 earnings. Here is a breakdown of the information Brightview Holdings presented to its investors. ...

BrightView Reports Record Earnings and Optimistic Outlook

Brightview Holdings (BV) has disclosed a new risk, in the Environmental / Social category. Brightview Holdings faces significant risks related to i...

Brightview Holdings Faces ESG Challenges Amid Regulatory Scrutiny and Market Sentiment

In a report released yesterday, Toni Kaplan from Morgan Stanley maintained a Hold rating on BrightView Holdings (BV – Research Report), with a pric...

BrightView Holdings: Stability and Solid Fundamentals Justify Hold Rating Amid Limited Upside Potential

William Blair analyst Tim Mulrooney upgraded BrightView (BV) to Outperform from Market Perform without a price target Despite the post-earnings sel...

BrightView upgraded to Outperform from Market Perform at William Blair

BrightView Holdings (BV – Research Report) received a Buy rating and price target from William Blair analyst Tim Mulrooney yesterday. The company's...

Positive Report for BrightView Holdings (BV) from William Blair

Loop Capital raised the firm's price target on BrightView (BV) to $20 from $18 and keeps a Buy rating on the shares. The firm cites the company's i...

BrightView price target raised to $20 from $18 at Loop Capital

Press Releases

BrightView Announces Increase and Extension of Receivables Financing Facility

BrightView to Participate in Upcoming CJS Securities Investor Conference

BrightView Holdings, Inc. Announces Third Quarter Fiscal Year 2024 Earnings Release Date, Conference Call and Webcast

BrightView Reports Third Quarter Earnings With Record EBITDA; Reaffirms Midpoint of Full Year Revenue, EBITDA, and Margin Guidance, and Raises Free Cash Flow Guidance

Comments

BrightView Hldgs

Vendite allo scoperto

BrightView Hldgs (NYSE:BV) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO